Bradley Curtis Carthon

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 29 papers. Top paper: “18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial”.

18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial

The Lancet(2021)10.1016/s0140-6736(21)00581-x

N/A

6.4DataRank · unranked

186 citations

Eduard Schreibmann, Subir Goyal, Raghuveer Halkar, Bruce Hershatter, Peter J. Rossi +14 more

Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808

Clinical Genitourinary Cancer(2023)10.1016/j.clgc.2023.06.012

N/A

0.261DataRank · unranked

4 citations

Se Eun Kim, David F. McDermott, Janice P. Dutcher, Mäneka Puligandla, Judith Manola +10 more

Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer

The Oncologist(2025)10.1093/oncolo/oyaf284

N/A

0.165DataRank · unranked

2 citations

R. Donald Harvey, Christina Wu, Elise Hitron, Hannah Collins, Suzanne Scott +7 more

Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.738

N/A

0DataRank · unranked

1 citations

Yuan Liu, Dylan J. Martini, Julie M. Shabto, Elise Hitron, Greta Russler +11 more

Novel risk scoring system for metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (C).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.734

N/A

0DataRank · unranked

1 citations

Dylan J. Martini, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Elise Hitron +8 more

Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.563

N/A

0DataRank · unranked

1 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Elise Hitron +12 more

Prostate Cancer: Community Education and Disparities in Diagnosis and Treatment

The Oncologist(2021)10.1002/onco.13749

N/A

0DataRank · unranked

33 citations

Hannah Claire Sibold, Shannon Blee, Rebecca D. Pentz, Bradley Curtis Carthon

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13868

N/A

0DataRank · unranked

43 citations

Subir Goyal, Yuan Liu, Sean T. Evans, T. Anders Olsen, Katherine Case +14 more

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13922

N/A

0DataRank · unranked

32 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen, Sean T. Evans +17 more

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002851

N/A

0DataRank · unranked

30 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Emilie Elise Hitron +13 more

Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options

The Oncologist(2021)10.1002/onco.13848

N/A

0DataRank · unranked

11 citations

Jacqueline T. Brown, Limeng Wan, Yuan Liu, Greta Russler, Lauren Yantorni +8 more

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Frontiers in Oncology(2021)10.3389/fonc.2021.701345

N/A

0DataRank · unranked

9 citations

Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod +12 more

Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.01.002

N/A

0DataRank · unranked

5 citations

Yuan Liu, Theresa Gillespie, Adeboye O. Osunkoya, Bradley Curtis Carthon, Mehmet Asım Bilen +8 more

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

Cancer Treatment and Research Communications(2021)10.1016/j.ctarc.2021.100393

N/A

0DataRank · unranked

4 citations

Meredith R. Kline, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Greta Russler +9 more

Phase II trial of opaganib in patients with metastatic castration-resistant prostate cancer progressing on abiraterone or enzalutamide (NCT04207255).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps191

N/A

0DataRank · unranked

3 citations

Charles D. Smith, Terry F. Plasse, Besim Öğretmen, Shikhar Mehrotra, Theodore Stewart Gourdin +6 more

Association of basophil to lymphocyte ratio (BLR) with clinical outcomes in metastatic hormone sensitive prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17049

N/A

0DataRank · unranked

0 citations

Limeng Wan, Yuan Liu, Jacqueline T. Brown, Greta Russler, Lauren Yantorni +7 more

Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.03.016

N/A

0DataRank · unranked

25 citations

Katherine E. Smith, Limeng Wan, Jacqueline T. Brown, Greta Russler, Lauren Yantorni +9 more

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2022)10.1093/oncolo/oyac236

N/A

0DataRank · unranked

13 citations

Deepak Ravindranathan, Yuan Liu, Dylan J. Martini, Jacqueline T. Brown, Bassel Nazha +8 more

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Journal of Immunotherapy and Precision Oncology(2022)10.36401/jipo-22-2

N/A

0DataRank · unranked

1 citations

T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron +12 more

478 Real-world outcomes in patients with penile squamous cell carcinoma (pSCC) receiving immune checkpoint inhibitors (ICI)

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0478

N/A

0DataRank · unranked

3 citations

Subir Goyal, Jacqueline Brown, Bradley Curtis Carthon, Ömer Küçük, Greta R. McClintock +5 more

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad154

N/A

0DataRank · unranked

12 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, Dylan J. Martini, Bassel Nazha +13 more

Association of baseline inflammatory biomarkers with outcomes in penile squamous cell carcinoma (pSCC) treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.11

N/A

0DataRank · unranked

2 citations

Subir Goyal, Jacqueline T. Brown, Bradley Curtis Carthon, Ömer Küçük, Greta Russler McClintock +5 more

Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

(2023)10.1158/1078-0432.c.6532368.v1

N/A

0DataRank · unranked

0 citations

Nizar M. Tannir, Othon Iliopoulos, Richard J. Lee, Melinda L. Telli, Alice C. Fan +15 more

PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation

Cancer(2024)10.1002/cncr.35465

N/A

0DataRank · unranked

6 citations

Katherine Case, Derrik Gratz, Kathryn L. Pellegrini, Elizabeth Beagle, Thomas M. Schneider +12 more

Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-19

N/A

0DataRank · unranked

4 citations

Subir Goyal, Katherine Case, T. Anders Olsen, Shalini Vemuru, Ahmet Yıldırım +8 more

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Cancer Medicine(2020)10.1002/cam4.2932

N/A

0DataRank · unranked

18 citations

Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline T. Brown, Emilie Elise Hitron +11 more

Phase 2 Study of Perioperative Lenvatinib with Pembrolizumab in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma 3215

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1039

N/A

0DataRank · unranked

0 citations

BaoHan T. Vo, Mehmet Asım Bilen, Yuan Liu, Amir H. Davarpanah, Bassel Nazha +16 more

Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database

Clinical and Translational Radiation Oncology(2020)10.1016/j.ctro.2020.11.002

N/A

0DataRank · unranked

14 citations

Jim Zhong, Yuan Liu, Chao Zhang, Adeboye O. Osunkoya, Shreyas Joshi +7 more

A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2697

N/A

0DataRank · unranked

14 citations

R. Donald Harvey, Bradley Curtis Carthon, Zhengjia Chen, Colleen Lewis, Hanna Collins +16 more